Efeito imunomodulador do alcaloide sintético MHTP na inflamação pulmonar alérgica experimental

• Ano de defesa: 2016
• Autor(a) principal: Ferreira, Laércia Karla Diega Paiva
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal da Paraíba; Brasil; Farmacologia; Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos; UFPB
• Palavras-chave em Português: MHTP; Alcaloide Sintético; Inflamação Pulmonar; Asma Th2; Imunomodulação; Instilação Nasal; Synthetic Alkaloid; Pulmonary Inflammation; Th2 Asthma; Immunomodulation; Nasal Instillation; CIENCIAS BIOLOGICAS::FARMACOLOGIA
• Link de acesso: https://repositorio.ufpb.br/jspui/handle/tede/8824

The synthetic alkaloid 2-methoxy-4-(7-methoxy-1,2,3,4- tetrahydroisoquinolin-1-yl) phenol encoded as MHTP, has a 93.45% yield and it had no genotoxic effect with low acute toxicity in preclinical analyses, with LD50 higher than 1000 mg / kg. The MHTP presented vasorelaxant and anti-inflammatory effects in acute inflammation models by orally administration. The aim of this study was to evaluate the immunomodulatory effect of MHTP, administered intranasally (in) in experimental allergic pulmonary inflammation induced by ovalbumin (OVA) by means of allergic (measurement of serum IgE) and inflammatory parameters (cell migration and production of cytokines, the fluid broncoalveolar- washed BAL, mucus production and histopathological pulmonary remodeling). Female BALB / c mice were sensitized with OVA at days 0 and 12 of the experimental protocol and on days 19 and 22 were treated via i.n. MHTP with the doses of 2.5 and 5 mg / kg or dexamethasone (2 mg/kg). After each treatment was aerosol challenged with OVA for 30 minutes daily; 24 hours after the last challenge, it was collected biological material for evaluation of allergic lung inflammation characteristic on allergic asthma. Treatment with MHTP at dose of 2.5 mg/kg decreased (p<0,05) the migration of total lymphocytes, (p<0,0001) the lymphocytes CD4+ and production of the cytokines IL-13, IL-4, IL-17 and IL-10. The dose of 5 mg/kg, in turn, decreased (p <0,05) the production of OVA-specific IgE and migration of lymphocytes CD3+; (p<0,0001) migration of leukocytes, total lymphocytes CD4+, macrophages and (p<0,001) eosinophils; (p<0,0001) the percentage of granulocytes; the production of the cytokines IL-13, IL-4, IL-17 and IL- 10. In addition, MHTP reduced inflammatory histopathological parameters such as hyperplasia and hypertrophy of goblet cells and mucus overproduction. The results infer that the immunomodulatory mechanism of MHTP is related to regulation of Th2 profile that is responsible for generating and maintaining allergic pulmonary inflammation process characteristic of allergic asthma.